Macquarie University
The Macquarie University Node supports a variety of imaging, specialising in neurodegenerative and neurocognitive imaging and has significant experience with pharma-sponsored clinical trials. Macquarie boasts a fully integrated radiology and molecular imaging department with a full medical imaging suite including CT, MRI, PET, located within Macquarie University Hospital (MUH). Also on the Macquarie University campus are the Magnetoencephalography (MEG) and related electrophysiological recording technologies, located within the Australian Hearing Hub.
As part of MQ Health, the Macquarie University Node has access to research-driven clinicians, in addition to large and varied patient cohorts. Our collaboration with the Macquarie University Clinical Trials Unit enables a translational research pathway from basic human research through phase I to phase IV clinical trials. The Macquarie Node’s integrated design allows for multi-modality scheduling for time critical studies. Co-location of the only child MEG in the Southern Hemisphere and a prototype system developed for use with hearing aid devices within the Australian Hearing Hub provides academic and translational research capabilities.
Capabilities
Positron Emission Tomography (PET)
Magnetic Resonance Imaging (MRI) x 2
Computed Tomography (CT)
Magnetoencephalography (MEG) – adult, child and cochlear compatible
Single Photon Emission Computed Tomography (SPECT)
DEXA (bone density)
Ultrasound
X-Ray
Access to radiotherapy
The Team
